# Attovia Therapeutics, Inc. (ATTO) insider trading

> In the 12 months to Nov 19, 2026, 2 ATTO insiders reported open-market sales of $4.5M across 2 filings; 6 insiders bought $52.4M.

Canonical: https://massive.com/quote/atto/insider-trading
Latest filing: 2026-10-08 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $4.5M | 2 filings · 2 insiders |
| Open-market purchases | $52.4M | 6 filings |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Broad Street Principal Investments, L.L.C. | Other | $2.3M | $10.3M | 2 | — | 2026-08-28 |
| Colin Walsh | Director | $2.3M | $10.3M | 2 | — | 2026-08-28 |
| Jeremy Green | 10% owner | — | $10.2M | 1 | — | 2026-08-07 |
| FHMLS XI, L.L.C. | 10% owner | — | $10.0M | 1 | — | 2026-08-06 |
| venBio Global Strategic Fund IV, L.P. | 10% owner | — | $6.5M | 1 | — | 2026-08-10 |
| Sanofi | 10% owner | — | $5.1M | 1 | — | 2026-08-07 |

## Open-market trades by filing

8 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-08-28 | 2026-08-05 | Broad Street Principal Investments, L.L.C. | Other | Sale | 105,807 | $21.28 | $2.3M | 62,374 | — |
| 2026-08-28 | 2026-08-05 | Broad Street Principal Investments, L.L.C. | Other | Purchase | 585,000 | $17.58 | $10.3M | 3,020,632 | — |
| 2026-08-28 | 2026-08-05 | Colin Walsh | Director | Sale | 105,807 | $21.28 | $2.3M | 74,870 | — |
| 2026-08-28 | 2026-08-05 | Colin Walsh | Director | Purchase | 585,000 | $17.58 | $10.3M | 3,020,632 | — |
| 2026-08-10 | 2026-08-06 | venBio Global Strategic Fund IV, L.P. | 10% owner | Purchase | 382,352 | $17.00 | $6.5M | 4,181,367 | — |
| 2026-08-07 | 2026-08-06 | Jeremy Green | 10% owner | Purchase | 600,000 | $17.00 | $10.2M | Multiple accounts | — |
| 2026-08-07 | 2026-08-06 | Sanofi | 10% owner | Purchase | 300,000 | $17.00 | $5.1M | 1,082,855 | — |
| 2026-08-06 | 2026-08-06 | FHMLS XI, L.L.C. | 10% owner | Purchase | 588,235 | $17.00 | $10.0M | 6,154,213 | — |

## Other insider activity (not market trades)

- Other: 14 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- **Counted once**: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

## FAQ

### Has Attovia Therapeutics, Inc.'s CEO sold stock?

No. Tao Fu and Attovia Therapeutics, Inc. (CEOs) made no open-market sales filed as CEO in the last 12 months.

### How current is ATTO’s insider data?

These are ATTO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The ATTO Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=ATTO&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Attovia Therapeutics, Inc. (ATTO) stock price](https://massive.com/quote/atto.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
